XIGDUO
Swiss trademark · 634948 · Word mark · In force
Register entry
- Registration number
- 634948
- Application number
- 57536/2012
- Status
- In force
- Type
- Word mark
- Filed
- Jun 20, 2012
- Registered
- Oct 8, 2012
- Published
- Oct 8, 2012
- Protected until
- Jun 20, 2032
- Priority
- 02.02.2012 US
- Language of procedure
- German
- Source
- Swissreg
Goods and services
Pharmaceuticals
Pharmazeutische Präparate für den Humangebrauch für die Behandlung oder Prävention von metabolischen Störungen, nämlich Diabetes, Fettleibigkeit, Hyperlipidämie, Insulinresistenz, metabolisches Syndrom.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 14, 2022
Renewed
Published in Swissreg on 14.04.2022
- Oct 6, 2020
Agent’s address changed
- Representative
- Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49, Postfach, 8027 Zürich → Keller Schneider Patent- und Markenanwälte AG (Zürich), Beethovenstrasse 49, Postfach, 8027 Zürich
Published in Swissreg on 06.10.2020
- Apr 19, 2017
Agent’s address changed
- Representative
- Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich → Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49, Postfach, 8027 Zürich
Published in Swissreg on 19.04.2017
- May 6, 2014
Transferred
- Owner
- Bristol-Myers Squibb Company, 345 Park Avenue, New York, NY 10154, USA → AstraZeneca AB, Vastra Malarehamnen 9, 15185 Södertälje, Sweden
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich
Published in Swissreg on 06.05.2014
- Oct 8, 2012
Registered
Published in Swissreg on 08.10.2012
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.